Missing Components of Receptor Status Among Women With Invasive Breast Cancer

IMPORTANCE: There are well-known differences in patient outcomes and effective therapeutic options across subtypes of breast cancer (BC), defined by the status of estrogen receptor, progesterone receptor, and erb-B2 receptor tyrosine kinase 2 (ERBB2 [formerly HER2]) expression, making testing for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephens, Julie A., Fisher, James L., Wesolowski, Robert, Paskett, Electra D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450568/
https://www.ncbi.nlm.nih.gov/pubmed/37615986
http://dx.doi.org/10.1001/jamanetworkopen.2023.30791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450568/
https://www.ncbi.nlm.nih.gov/pubmed/37615986
http://dx.doi.org/10.1001/jamanetworkopen.2023.30791

Ejemplares similares